Eastman, UNC Ink Research Pact - Analyst Blog
27 Fevereiro 2013 - 1:50PM
Zacks
Eastman Chemical
Company (EMN) has entered into an agreement with Chapel
Hill-based University of North Carolina (UNC) to conduct research
in the fields of chemistry and materials science. The collaboration
complements the earlier announced agreement between Eastman
Chemical and North Carolina State University.
The agreement offers at least $1.5 million over a period of 6 years
to aid the collaboration between Eastman Chemical scientists and
UNC scientists, staff and students. Eastman Chemical and UNC will
make joint efforts to bring innovative new ideas and technologies
in market that run faster than traditional approaches.
This collaboration involves a series of programs including research
projects, visits to both the UNC campus and Eastman Chemical
manufacturing facilities and identifying and applying for federal
or other funding opportunities.
Under the agreement, UNC’s chemistry faculty members will address
Eastman Chemical developed problem statements or ‘Requests for
Proposals’ (RFP) by submitting research proposals periodically.
Eastman Chemical will then select the given UNC proposals for
funding each year. The first decision regarding the projects is
expected in spring 2013.
Last month, Eastman Chemical released its fourth-quarter 2012
results. The company slipped to a loss in the quarter hurt by
losses related to pension benefit and other charges. Adjusted
earnings, however, matched the Zacks Consensus Estimate. Revenues
rose at a double-digit clip riding on the contributions of Solutia
acquisition, but missed the Zacks Consensus Estimate.
Eastman Chemical’s diversified chemical portfolio, along with its
integrated and diverse downstream businesses remains its strength.
It also benefits from business restructuring, cost-cutting measures
and increased capacity additions. However, the company remains
exposed to weak pricing. Uncertainty regarding the timing of a
recovery in Europe also remains as overhang.
Eastman Chemical currently maintains a Zacks Rank #2 (Buy).
Other companies in the chemical
industry worth considering are Akzo Nobel NV
(AKZOY), Arkema S.A. (ARKAY) and BASF
SE (BASFY). All of these hold a Zacks Rank #1 (Strong
Buy).
AKZO NOBEL NV (AKZOY): Free Stock Analysis Report
ARKEMA-ADR (ARKAY): Get Free Report
BASF SE (BASFY): Free Stock Analysis Report
EASTMAN CHEM CO (EMN): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Arkema (PK) (USOTC:ARKAY)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Arkema (PK) (USOTC:ARKAY)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Arkema (PK) da OTCMarkets bolsa de valores: 0 artigos recentes
Mais Notícias de Arkema (PC)